MDXH
Income statement / Annual
Last year (2024), MDxHealth S.A.'s total revenue was $90.05 M,
an increase of 28.29% from the previous year.
In 2024, MDxHealth S.A.'s net income was -$38.07 M.
See MDxHealth S.A.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$90.05 M |
$70.19 M |
$37.05 M |
$22.24 M |
$18.46 M |
$11.79 M |
$28.34 M |
$40.51 M |
$29.87 M |
$17.47 M |
| Cost of Revenue |
$34.91 M
|
$26.26 M
|
$17.84 M
|
$11.68 M
|
$10.42 M
|
$11.93 M
|
$11.65 M
|
$10.20 M
|
$10.10 M
|
$6.91 M
|
| Gross Profit |
$55.14 M
|
$43.93 M
|
$19.22 M
|
$10.56 M
|
$8.04 M
|
-$144.00 K
|
$16.69 M
|
$30.31 M
|
$19.76 M
|
$10.56 M
|
| Gross Profit Ratio |
0.61
|
0.63
|
0.52
|
0.48
|
0.44
|
-0.01
|
0.59
|
0.75
|
0.66
|
0.6
|
| Research and Development Expenses |
$10.55 M
|
$6.38 M
|
$7.56 M
|
$5.59 M
|
$4.54 M
|
$9.00 M
|
$1.81 M
|
$1.83 M
|
-$332.00 K
|
$2.10 M
|
| General & Administrative Expenses |
$54.95 M
|
$23.01 M
|
$23.54 M
|
$27.19 M
|
$25.80 M
|
$5.68 M
|
$6.19 M
|
$5.35 M
|
$3.95 M
|
$2.97 M
|
| Selling & Marketing Expenses |
$6.44 M
|
$36.92 M
|
$26.58 M
|
$3.02 M
|
$2.81 M
|
$4.43 M
|
$9.07 M
|
$8.15 M
|
$7.61 M
|
$6.02 M
|
| Selling, General & Administrative Expenses |
$61.40 M
|
$59.93 M
|
$50.12 M
|
$30.22 M
|
$28.61 M
|
$10.10 M
|
$15.26 M
|
$13.51 M
|
$11.56 M
|
$8.99 M
|
| Other Expenses |
$7.92 M
|
$4.96 M
|
-$559.00 K
|
$1.60 M
|
$2.01 M
|
$23.92 M
|
$31.71 M
|
$27.25 M
|
$21.39 M
|
$13.85 M
|
| Operating Expenses |
$79.86 M
|
$71.26 M
|
$57.12 M
|
$37.41 M
|
$35.17 M
|
$43.03 M
|
$48.78 M
|
$42.58 M
|
$32.61 M
|
$24.94 M
|
| Cost And Expenses |
$114.77 M
|
$97.52 M
|
$74.95 M
|
$49.08 M
|
$45.58 M
|
$54.95 M
|
$60.44 M
|
$52.78 M
|
$42.71 M
|
$31.85 M
|
| Interest Income |
$1.08 M
|
$1.09 M
|
$125.00 K
|
$11.00 K
|
$4.00 K
|
$10.00 K
|
$21.00 K
|
$0.00
|
$6.00 K
|
$13.00 K
|
| Interest Expense |
$7.63 M
|
$5.77 M
|
$2.74 M
|
$1.88 M
|
$1.54 M
|
$516.00 K
|
$82.00 K
|
$122.00 K
|
$0.00
|
$99.00 K
|
| Depreciation & Amortization |
$8.04 M
|
$6.86 M
|
$4.91 M
|
$3.04 M
|
$3.33 M
|
$3.42 M
|
$2.94 M
|
$2.21 M
|
$1.72 M
|
$881.00 K
|
| EBITDA |
-$22.02 M |
-$30.47 M |
-$36.39 M |
-$24.09 M |
-$23.98 M |
-$39.74 M |
-$29.47 M |
-$10.19 M |
-$11.57 M |
-$13.50 M |
| EBITDA Ratio |
-0.24
|
-0.43
|
-0.98
|
-1.08
|
-1.3
|
-3.37
|
-1.04
|
-0.25
|
-0.39
|
-0.77
|
| Operating Income Ratio |
-0.27
|
-0.39
|
-1.02
|
-1.21
|
-1.47
|
-3.66
|
-1.13
|
-0.3
|
-0.43
|
-0.82
|
| Total Other Income/Expenses Net |
-$12.97 M
|
-$15.77 M
|
-$6.14 M
|
-$2.16 M
|
-$1.54 M
|
-$506.00 K
|
-$393.00 K
|
-$127.00 K
|
-$441.00 K
|
-$91.00 K
|
| Income Before Tax |
-$37.69 M
|
-$43.10 M
|
-$44.04 M
|
-$29.00 M
|
-$28.66 M
|
-$43.68 M
|
-$32.49 M
|
-$12.40 M
|
-$13.29 M
|
-$14.47 M
|
| Income Before Tax Ratio |
-0.42
|
-0.61
|
-1.19
|
-1.3
|
-1.55
|
-3.71
|
-1.15
|
-0.31
|
-0.44
|
-0.83
|
| Income Tax Expense |
$382.00 K
|
$1.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$575.00 K
|
-$41.00 K
|
-$113.00 K
|
-$113.00 K
|
$86.00 K
|
| Net Income |
-$38.07 M
|
-$43.10 M
|
-$44.04 M
|
-$29.00 M
|
-$28.66 M
|
-$43.10 M
|
-$32.45 M
|
-$12.29 M
|
-$13.17 M
|
-$14.47 M
|
| Net Income Ratio |
-0.42
|
-0.61
|
-1.19
|
-1.3
|
-1.55
|
-3.66
|
-1.15
|
-0.3
|
-0.44
|
-0.83
|
| EPS |
-0.78 |
-1.66 |
-2.78 |
-2.38 |
-3.44 |
-6.89 |
-5.63 |
-2.46 |
-2.86 |
-3.51 |
| EPS Diluted |
-1.16 |
-1.66 |
-2.78 |
-2.38 |
-3.44 |
-6.89 |
-5.63 |
-2.46 |
-2.86 |
-3.51 |
| Weighted Average Shares Out |
$48.67 M
|
$25.91 M
|
$15.87 M
|
$12.19 M
|
$8.32 M
|
$6.26 M
|
$5.76 M
|
$4.99 M
|
$4.61 M
|
$4.13 M
|
| Weighted Average Shares Out Diluted |
$48.67 M
|
$25.91 M
|
$15.87 M
|
$12.19 M
|
$8.32 M
|
$6.26 M
|
$5.76 M
|
$4.99 M
|
$4.61 M
|
$4.13 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
